首页> 外国专利> Multiparticulate Pharmaceutical Form Comprising Pellets With a Matrix Which Influences the Delivery of a Modulatory Substance

Multiparticulate Pharmaceutical Form Comprising Pellets With a Matrix Which Influences the Delivery of a Modulatory Substance

机译:包含颗粒的多颗粒药物形式,其基质会影响调制物质的输送

摘要

The invention relates to a multiparticulate pharmaceutical form, comprising pellets with a multilayer structure for controlled active ingredient release, comprising a) optionally a neutral core (nonpareilles), b) an inner controlling layer comprising a substance having a modulating effect, which is embedded in a matrix which influences the delivery of the modulatory substance and which comprises pharmaceutically usable polymers, waxes, resins and/or proteins, and where appropriate an active ingredient, c) an active ingredient layer comprising an active pharmaceutical ingredient and, where appropriate, a substance having a modulating effect, d) an outer controlling layer comprising at least 60% by weight of one or a mixture of a plurality of (meth) acrylate copolymers where the outer controlling layer has a thickness from 20 to less than 55 μm and contains 0,1 to 10% by weight of glycerol monostearate, where the multiparticulate pharmaceutical form contains 20 to 60% by weight of the pellets, which are compressed in mixture with 80 to 40% by weight of an outer phase which consists from 50 to 100% by weight of a cellulose or a derivate of cellulose and optionally 0 to 50% by weight of further pharmaceutical excipients.
机译:本发明涉及一种多颗粒药物形式,其包括具有用于控制活性成分释放的多层结构的小丸,其包括:a)任选地中性核(无颗粒),b)包含具有调节作用的物质的内部控制层,其被包埋在影响调节物质传递的基质,其包含可药用的聚合物,蜡,树脂和/或蛋白质,以及在适当情况下为活性成分,c)包含活性药物成分和适当物质的活性成分层具有调节作用,d)外控制层,其包含至少60重量%的一种或多种(甲基)丙烯酸酯共聚物的混合物,其中外控制层的厚度为20至小于55μm,并且包含0 0.1至10%重量的单硬脂酸甘油酯,其中多颗粒药物形式含有20至60%重量的pe小片,其与80至40重量%的外相混合压制,所述外相由50至100重量%的纤维素或纤维素衍生物和任选0至50重量%的其他药物赋形剂组成。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号